Correction to “Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases ( ERN ‐ RND )”

Documents similaires

• European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERNEURO‐NMD)
  par: Philip Van Damme, et autres
  Publié: (2024)
• Neurological autoimmunity in patients with non‐pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles
  par: Georgios Mangioris, et autres
  Publié: (2024)
• Diagnostic Impasse and Wandering in Patients With Rare Neuromuscular Diseases: Insights Into Patient Characteristics From the French National Network for Rare Neuromuscular Diseases (FILNEMUS) and the French National Rare Disease Database (BNDMR)
  par: Rémy Dumas, et autres
  Publié: (2025)
• Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia: A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC‐FTD)
  par: Dirk van Paassen, et autres
  Publié: (2024)
• Early history of the European Journal of Neurology. A mirror of the evolution of Europe after 1989
  par: François Boller, et autres
  Publié: (2024)